Found 5 results
↓ CSVName | Type of Offering | Accepted Date |
---|---|---|
DiaMedica Therapeutics Inc.
See All Filings
|
D | 2024-07-02 16:07:07 |
Amount To Be Raised
$11,800,000
Associated Brokers / Dealers
N/A
CIK Number
0001401040
Filed Document
0001235802-24-000055
Exclusions or Exemptions
506b
Accepted Date
2024-07-02 16:07:07
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
MINNESOTA
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
DiaMedica Therapeutics Inc.
See All Filings
|
D | 2018-04-17 13:46:17 |
Amount To Be Raised
$344,348
Associated Brokers / Dealers
N/A
CIK Number
0001401040
Filed Document
0001140361-18-018770
Exclusions or Exemptions
506b
Accepted Date
2018-04-17 13:46:17
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
MINNESOTA
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
DiaMedica Therapeutics Inc.
See All Filings
|
D | 2023-06-27 16:11:59 |
Amount To Be Raised
$37,536,853
Associated Brokers / Dealers
N/A
CIK Number
0001401040
Filed Document
0001235802-23-000074
Exclusions or Exemptions
506b
Accepted Date
2023-06-27 16:11:59
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
MINNESOTA
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
DiaMedica Therapeutics Inc.
See All Filings
|
D | 2021-10-05 17:35:29 |
Amount To Be Raised
$29,999,995
Associated Brokers / Dealers
N/A
CIK Number
0001401040
Filed Document
0001235802-21-000122
Exclusions or Exemptions
506b
Accepted Date
2021-10-05 17:35:29
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
MINNESOTA
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
DiaMedica Therapeutics Inc.
See All Filings
|
D | 2023-04-18 16:30:59 |
Amount To Be Raised
$750,000
Associated Brokers / Dealers
N/A
CIK Number
0001401040
Filed Document
0001235802-23-000041
Exclusions or Exemptions
506b
Accepted Date
2023-04-18 16:30:59
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
MINNESOTA
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|